SAXENDA
SAXENDA
Approved
DIN Number
02437899
Drug Class
Human
Market Date
May 27, 2015
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02437899
AIG Number0152718001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A10BJ02 LIRAGLUTIDE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification68:20.06
Health Canada Classification
ACTIVE INGREDIENTS (1)
LIRAGLUTIDEActive
Strength: 6 MG / ML
Monograph: LIRAGLUTIDE